ViewRay's revenue plummets in Q3
November 6, 2020 -- Image-guided radiation therapy vendor ViewRay announced its revenue for the third quarter was nearly half of what it was a year ago.
Isotopia partners with Y-mAbs on radioisotope
November 6, 2020 -- Isotopia Molecular Imaging is collaborating with biopharmaceutical company Y-mAbs Therapeutics for the supply of the medical radioisotope no-carrier-added lutetium-177.
Shine makes 1st commercial sales of Lu-177
November 4, 2020 -- Medical isotope firm Shine Medical Technologies made its first commercial sales of its lutetium-177 (Lu-177) therapeutic isotope to multiple customers.
Prelude highlights ASTRO data on breast cancer risk test
October 30, 2020 -- Molecular diagnostics developer Prelude presented data at the American Society for Radiation Oncology (ASTRO) 2020 annual meeting showing that its DCISionRT test can reclassify breast cancer risk in women.
Accuray's fiscal Q1 revenue declines
October 30, 2020 -- Radiation oncology firm Accuray has released financial results for its first quarter of fiscal 2021 that show a drop in revenue from last year.
Race, ethnicity vary in radiation therapy trials
October 29, 2020 -- Asian Americans are underrepresented in U.S. radiation therapy clinical trials relative to population size, while Black Americans are nearly on par, according to a study presented on October 27 at the American Society for Radiation Oncology annual meeting.
Radiation therapy access grows, but not in rural areas
October 29, 2020 -- The number of radiation therapy facilities in the U.S. has grown by 17% in recent years, but they tend to be based in more populated areas, so some rural patients may still be missing out, according to a new study presented at the American Society for Radiation Oncology annual meeting.
Varian's revenues slip for Q4, full year
October 28, 2020 -- Radiation oncology vendor Varian Medical Systems saw its revenues fall slightly for the full year and fourth quarter of its 2020 fiscal year, although the company was able to maintain profitability in the year's final quarter.
Accuray partners with Brainlab in radiation therapy
October 28, 2020 -- Radiation oncology firm Accuray has signed an agreement with Brainlab to make that company's treatment planning software available to users of Accuray's CyberKnife radiosurgery system.
Small study supports radiation before CAR-T therapy
October 28, 2020 -- A small, retrospective study suggests that radiation therapy may be administered prior to personalized T-cell therapy in patients with multiple myeloma without causing complications. Results were presented October 27 at the American Society for Radiation Therapy annual meeting.
Special Feature
IMV: Imaging boosts precision in radiation therapy

Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more